| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | $1.77K |
| Cost of Revenue | – | – | – | – | $246.69K |
| Gross Profit | – | – | – | – | -$244.92K |
| Operating Expenses | $1.83M | $3.47M | $96.17K | $126.27K | $61.31K |
| R&D | $662.48K | $2.40M | – | – | – |
| SG&A | $1.16M | $1.07M | $96.17K | $126.27K | $52.54K |
| Operating Income | -$1.83M | -$3.47M | -$96.17K | -$126.27K | -$306.23K |
| Interest Expense | $320.05K | $80.64K | $66.79K | $59.06K | $42.91K |
| Tax Expense | -$2.72K | – | – | – | – |
| Net Income | -$2.53M | -$3.54M | -$137.33K | -$195.59K | $353.75K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |